Researchers sought to determine accessibility and use of palliative care among patients with advanced renal cell carcinoma.
Researchers sought to identify social disparities in diagnosis and treatment among patients with bladder cancer.
Prospective cohort study sought to determine the association between impairments identified through GA and outcomes of radical cystectomy for bladder cancer.
Using porcine bladders, researchers investigated whether bladder pressure affects the extent to which gemcitabine penetrates the bladder wall with this treatment modality.
Researchers analyzed data from patients with metastatic urothelial cancer to determine whether tumor mutation burden was associated with immune-related AEs among patients treated with immune checkpoint inhibitors.
Results of a survey show differences between patients and healthcare providers regarding key aspects of bladder cancer treatment and outcomes.
Researchers present data comparing outcomes of radical cystectomy for female and male patients with bladder cancer.
Study reveals patients’ and survivors’ perception of discussions with their healthcare team regarding options, costs, and impact on work related to prostate cancer treatment.
Using the EPIC-CP tool, researchers sought to determine if early patient reports of quality of life improved over time in patients undergoing radiotherapy for prostate cancer.
A retrospective analysis evaluated the incidence of ONJ in patients who received VEGF-TKIs or immune-oncology therapy for mRCC and bone-targeted therapies for bone metastases.
Data analysis evaluated the associations between rates of treatment noncompletion and radiotherapy fractionation schedules for men with localized prostate cancer.
Researchers compared health-related quality of life and time to deterioration for patients with RCC treated with 2 starting doses of lenvatinib, combined with everolimus.
A retrospective analysis sought to determine the effect of hypertension on overall survival, response, and progression-free survival in patients with mRCC.
Retrospective study of more than 32,000 veterans sought to determine the incidence, management, and mortality of men with prostate cancer who experience depression.